Company Filing History:
2 out of 4 
2 out of 5 
1 out of 945 
Years Active: 2018-2024
Title: Innovator Ella Fremder: Pioneering Advances in Cancer Treatment
Introduction
Ella Fremder, an esteemed inventor based in Haifa, Israel, has made significant contributions to the field of cancer treatment. With a remarkable portfolio of five patents, Ella focuses on groundbreaking therapies that enhance patient care during challenging treatments.
Latest Patents
Among Ella's noteworthy inventions are two related patented technologies aimed at improving cancer treatment. Her latest patents describe methods involving the use of blocking agents to inhibit interleukin-1 (IL-1) activity. These agents, including IL-1α, IL-1β, and IL-1R, are designed for use in combination with radiotherapy. The innovative approach targets the host-induced IL-1 response in cancer patients receiving radiotherapy, aiming to increase the efficacy of the treatment and reduce adverse effects.
Career Highlights
Ella Fremder has established herself as a prominent figure in the biotech industry through her role in companies such as Oncohost Ltd. and New Phase Ltd. Her work emphasizes not only inventive excellence but also the practical application of her research in real-world medical settings.
Collaborations
Throughout her career, Ella has collaborated with esteemed professionals in the field, including Yuval Shaked and Eyal Jacob. These partnerships have enabled her to harness collective expertise and drive forward her innovative cancer treatments.
Conclusion
Ella Fremder's contributions to cancer treatment through her inventive spirit and dedication underscore the critical intersection of innovation and healthcare. As she continues to evolve her research and develop new inventions, her work promises to make a lasting impact on the future of cancer care.